New study tracks psoriatic arthritis treatment success across therapy lines
NCT ID NCT07417995
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study follows 400 adults with psoriatic arthritis who are starting a new biologic or targeted synthetic drug as part of their routine care. Researchers want to see if treatment response differs based on how many prior advanced therapies a person has tried, and whether blood tests can predict effectiveness. Participants will provide routine checkup data, symptom questionnaires, and blood samples before treatment and at 12 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal United Hospitals Bath NHS Foundation Trust
Bath, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection calm psoriatic arthritis?
- Can a once-daily pill tame psoriatic arthritis in everyday life?
- A single blood test may reveal whether a gene tied to transplant outcomes influences psoriatic arthritis risk.
- Can a 4-Minute chat rival a Dietitian's hour for heart health?
- Your plate may fight psoriatic arthritis: diet study tests food as medicine
- Real-World study tests whether aggressive early treatment improves psoriatic arthritis outcomes